Cbd

NextEvo launches Revive CBD Complex Curcumin and Hemp Extract

28-Sep-2022 By Asia Sherman

NextEvo Naturals has added Revive CBD Complex Curcumin and Hemp Extract to its line of water-soluble CBD products, formulated and clinically proven to maximize absorption.

Study: CBD has therapeutic potential for managing menopause

15-Sep-2022 By Danielle Masterson

The data offers preclinical evidence supporting further investigation of CBD as an option for post menopausal symptoms.

SPECIAL REPORT: Hemp-derived CBD… ‘We're operating in a constrained addressable market with a patchwork of state-based regulations’

02-Sep-2022 By Elaine Watson

“I see all these emails going around saying once the [2018] Farm Bill passes, CBD is legal in all 50 states… and that’s just not true,” observed one attorney in December 2018. Four years later, while a lot has changed, the FDA maintains that CBD is not...

CBD brand Trip expands its foothold in US, launches gummies with $12m fundraise

26-Aug-2022 By Elizabeth Crawford

After dominating the UK CBD space with help from a highly engaged online fanbase, CBD beverage, oil and gummy brand Trip is hoping to cement a similar position in the US – but this time with the additional aid of $12m in funding from prominent entrepreneurs...

AHPA’s updated Hemp Lexicon seeks to shed light on ‘full spectrum’ question

25-Aug-2022 By Hank Schultz

The American Herbal Products Association has released a new guidance document that seeks to bring clarity to hemp nomenclature, in particular what ought to be meant by the terms ‘broad spectrum’ and ‘full spectrum’ extracts.

Charlotte’s Web to hop on CBD sports bandwagon with new NSF-certified product line

15-Aug-2022 By Hank Schultz

CBD manufacturer Charlotte’s Web has announced the planned launch of a line of CBD products aimed at the sports market that will feature an NSF Certified for Sport mark.

NutraCast: Turning to CBD for mental health

08-Jul-2022 By Danielle Masterson

Between Covid-19, supply chain issues and inflation, life is taking a serious toll on mental health. But more and more people are looking for ways to address mental health without a prescription.

7 key takeaways from the CRN-ACI Legal, Regulatory & Compliance Summit

05-Jul-2022 By Stephen Daniells

NDIs, drug preclusions, the CBD stalemate, actions at the State level, and an impending supply chain nightmare around plastics were just some of the highlights from a recent conference in New York City.

CBD: The ultimate celebrity side hustle

01-Jul-2022 By Danielle Masterson

Whether they’re an investor, founder or spokesperson, public figures such as athletes and actors are benefitting from CBD’s therapeutic properties –and its ability to bring in the dough.

Majority of CBD products tested in study found to have at least some THC

29-Jun-2022 By Hank Schultz

A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.

Parliamentary group divided on proposals for new CBD approval system

29-Jun-2022 By Nicola Gordon-Seymour

Proposals to overhaul the UK Cannabidiol (CBD) approval system has led to tension among some members of the Secretariat Advisory Board (SAB) of the All-Party Parliamentary Group (APPG) that liaises with government to inform industry policies.

UK government urged to become world leader in cannabinoid innovation

28-Jun-2022 By Kavitha Sivasubramaniam

The UK could become a world leader in cannabinoid innovation by following 20 key recommendations, according to a just-published report.

FDA revisits safety of CBD for use in dietary supplements, industry not satisfied

23-Jun-2022 By Asia Sherman

Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.

Kemin enters hemp-CBD space with Luxiva distillates range

15-Jun-2022 By Stephen Daniells

Iowa-based Kemin is expanding its portfolio to introduce a range of USDA-certified organic, traceable, U.S.-grown hemp CBD distillates for use in health and wellness products.

Nutracast: The van Breemen Company launches following groundbreaking hemp study

10-Jun-2022 By Danielle Masterson

Lead scientist Richard van Breemen, along with his co-founder and CEO Jacob Crabtree joined us to discuss the research that caught the world’s attention.

UK FSA: EFSA’s safety concerns will not provoke CBD product removals

10-Jun-2022 By Shane Starling

EFSA’s decision this week to stop the clock on 150 CBD (cannabidiol) Novel Food applications and publish a litany of ‘data gaps’ does not threaten thousands of on-market CBD products in the UK, its Food Standards Agency (FSA) has told NutraIngredients.

HempRise introduces 5% CBD nanoemulsion

09-Jun-2022 By Danielle Masterson

The vertically-integrated supplier of hemp extracts and cannabinoid ingredients recently introduced HempNANO, its new concentrated nanoemulsion for water soluble applications.

Study: Many CBD products would trigger doping bans

09-Jun-2022 By Shane Starling

Almost a third of 23 tested CBD products contained traces of banned cannabinoids at levels that would have provoked doping infringements, according to a just-published study.

EFSA says CBD safety data “cannot currently be established”

08-Jun-2022 By Shane Starling

The European Food Safety Authority (EFSA) has issued a wide-ranging opinion calling for more safety data for CBD products that could challenge the Novel Foods status of many offerings in the nascent category across the bloc and beyond.

NutraWomen Wednesday: Paola Fernandez, Founder and CEO of High Hemp

25-May-2022 By Danielle Masterson

While working at her father’s cigar company, Paola Fernandez invented a ‘natural’ alternative to tobacco-based rolling paper. In 2016, High Hemp was born and sells its flagship hemp wraps along with CBD gummies and tinctures. In under 5 years, Fernandez...

Radicle Science highlights findings from large CBD study

09-May-2022 By Danielle Masterson

The company collected data directly from thousands of participants in their real world environment.

FDA slams Delta-8 THC sellers over claims

04-May-2022 By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

Thousands of additional CBD products added to FSA public list

28-Apr-2022 By Liza Laws

Thousands of CBD products have been added to the Food Standards Agency’s (FSA) public list this week allowing them to remain on the market.

CBD list chaos continues as FSA extends deadline to allow more companies to seek approval

22-Apr-2022 By Liza Laws

The deadline for companies wanting to submit its CBD products to be approved for sale has been extended by the Food Standards Agency (FSA).

Lawyer says guidelines for sale of CBD products are "nonsensical" and "discriminatory"

20-Apr-2022 By Liza Laws

Controversy has been sparked over Food Standards Agency (FSA) guidelines over the sale of CBD products which a lawyer says are "discriminatory".

CV Sciences reports 18% revenue drop for ‘challenging’ 2021

04-Apr-2022 By Stephen Daniells

San Diego-based CV Sciences, one of the bell-weather companies in the hemp and CBD space, has reported a decline in revenues for the past financial year, but new initiatives have positioned the company for long-term growth, says its CEO.

FDA, FTC slap seven CBD firms with COVID-19 warning letters

01-Apr-2022 By Hank Schultz

Seven marketers of CBD products received warning letters for making COVID-19 treatment claims as part of the ongoing joint FDA/FTC enforcement action.

UK’s FSA unveils list of permitted CBD products

01-Apr-2022 By Kavitha Sivasubramaniam

The UK’s Food Standards Agency (FSA) has released a list of cannabinoid (CBD) products which can be sold to consumers, becoming the first country globally to regulate the market for orally consumed, safe legal cannabis extracts.

NutraCast: Improving CBD bioavailability with SmartSorb delivery technology

18-Mar-2022 By Danielle Masterson

Regulation of CBD, or lack thereof, is one challenge that the CBD industry faces. Another is bioavailability, which is impacted by quality, delivery method, and pharmacokinetics.

Poll finds many parents don't understand CBD

15-Mar-2022 By Danielle Masterson

Despite the wide availability of CBD in its various forms—oil, topical ointments, tinctures, vaping and edibles— a recent poll shows parents are misinformed on CBD.

Six key supplement trends from Expo West 2022

15-Mar-2022 By Stephen Daniells

We walked and we talked, and we took photos, and here’s our editor’s list of 6 key trends for supplements from Expo West 2022 in Anaheim.

Factoring CBD into the athletic equation

03-Mar-2022 By Danielle Masterson

This year’s Sports & Active Nutrition Summit event launched with a focus on CBD in sports nutrition. While CBD/hemp products are still in a federal regulatory gray area, that hasn’t stopped product developers from flooding the market with new offerings....

CBD price per mg trending down, report finds

28-Feb-2022 By Danielle Masterson

Despite a whopping 3,561% gap between the most expensive and least expensive products across the CBD industry, the overall category is getting cheaper for consumers.

Best companies will prevail as CBD market goes through painful winnowing, CEO says

24-Feb-2022 By Hank Schultz

The hemp/CBD market is going through a reckoning but ultimately will emerge in a stronger position, said the head of one of few publicly traded companies in the sector.

NPA submits citizen’s petition demanding resolution on CBD issue

22-Feb-2022 By Hank Schultz

The Natural Products Association has filed a citizen’s petition calling for FDA to either rule that CBD is a legal dietary ingredient or to make a rule allowing enforcement discretion on the substance.

Trade organizations welcome Califf appointment as FDA commissioner

15-Feb-2022 By Stephen Daniells

Dr Robert Califf has been confirmed as the new commissioner of the Food & Drug Administration in a tight 50-46 vote in the US Senate.

Brains Bioceutical anticipates Spring launch of pharma-grade CBD ingredient

03-Feb-2022 By Nicola Gordon-Seymour

CBD producer, Brains Bioceutical, will launch natural plant-based cannabidiol (CBD) in the UK in the Spring following approval by the Food Standards Agency (FSA).

GNC partners with Pilot Flying J to provide supplements to travelers

31-Jan-2022 By Danielle Masterson

On-the-go GNC essentials are now available at participating locations coast-to-coast.

CBD companies told to provide sufficient toxicology data or risk losing product selling rights

31-Jan-2022 By Lynda Searby

Up to 40 CBD (cannabinoid) companies have been contacted by the UK Food Standards Agency (FSA) and told they have until 28 February to provide sufficient toxicology data or risk their products being removed from sale.

NutraCast: Vertosa CEO Ben Larson on rising growth of infused beverages

28-Jan-2022 By Danielle Masterson

Not long ago, the idea of hemp-infused beverages taking a share of the beer, wine and spirit sales would have been laughable. But some companies are laughing all the way to the bank.

FDA approves IND application for CBD product

24-Jan-2022 By Danielle Masterson

Researchers hope CBD could help combat opioid use disorder, but what does this IND mean for the supplement industry?

Kemin expands hemp-based ingredients offering with Driftless Extracts investment

20-Jan-2022 By Stephen Daniells

Iowa-based Kemin Industries has made a strategic investment in Wisconsin-based Driftless Extracts LLC, a USDA-certified organic hemp producer, processor, and ingredient supplier.

Hemp compounds block COVID-19, study finds

18-Jan-2022 By Danielle Masterson

Researchers found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, preventing a critical step in the process the virus uses to infect people.

New study explores CBD and CBN for sleep

11-Jan-2022 By Danielle Masterson

CBD brand CBDistillery in partnership with MoreBetter (dba Releaf App) recently announced the results from a 31-day study it calls the Sleep Pathfinder Mission utilizing CBDistillery's Regular Strength Sleep Synergy Tincture.

Leafreport finds over half CBD products mislabeled

10-Jan-2022 By Danielle Masterson

The CBD watchdog released a market analysis, revealing that of the 221 products tested, only 40% matched the labeled CBD strength and many contained the wrong type of CBD.

NEWS IN BRIEF

EFSA submission suggests CBD position statement imminent

07-Jan-2022 By Will Chu

The European Food and Safety Authority (EFSA) is expected to outline its position on the safety of cannabidiol (CBD) as a novel food in a move expected to aid in future novel food applications.

NutraWomen Wednesday: Sibyl Swift, PhD, VP of Scientific & Regulatory Affairs at cbdMD

05-Jan-2022 By Danielle Masterson

Sibyl Swift, PhD joined cbdMD in 2021 as a regulatory consultant before being named vice president for Scientific & Regulatory Affairs. Prior to joining cbdMD, Swift was the Senior VP for Scientific & Regulatory Affairs at the Natural Products...

CBD-alternative? Review shows PEA targets similar pathways, ‘but safer and legal’

15-Dec-2021 By Tingmin Koe

An ingredient commonly isolated from soybeans, peanuts, and egg yolks, has been shown in a recent review to act in similar pathways as cannabidiol (CBD), with researchers highlighting that it was a safer and legally recognised alternative.

Editor's Spotlight: Startup Focus

CBD startup partners athlete organisation 4CAST

29-Nov-2021 By Nikki Hancocks

London-based CBD drinks startup ThreeDots has announced a partnership with the athlete led media organisation 4CAST to see its products enter international markets.

Leafreport: Half of CBG products tested don't meet label claim

19-Nov-2021 By Danielle Masterson

With CBG more difficult to source than CBD, Leafreport sought to find out whether this meant a lot of CBG products were on the market that didn't meet label claims listing the amount of the cannabinoid shoppers should expect to find inside.